BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26530987)

  • 1. 3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system.
    Valenti D; Vacca RA; de Bari L
    J Bioenerg Biomembr; 2015 Dec; 47(6):493-506. PubMed ID: 26530987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvate.
    Lis P; Jurkiewicz P; Cal-Bąkowska M; Ko YH; Pedersen PL; Goffeau A; Ułaszewski S
    Oncotarget; 2016 Mar; 7(9):10153-73. PubMed ID: 26862728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
    Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
    Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: energy depletion, oxidative stress, and protein kinase activity modulation.
    Calviño E; Estañ MC; Sánchez-Martín C; Brea R; de Blas E; Boyano-Adánez Mdel C; Rial E; Aller P
    J Pharmacol Exp Ther; 2014 Feb; 348(2):324-35. PubMed ID: 24307199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells.
    Chen TC; Yu J; Nouri Nigjeh E; Wang W; Myint PT; Zandi E; Hofman FM; Schönthal AH
    Cancer Lett; 2017 Aug; 400():161-174. PubMed ID: 28450161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity.
    Galina A
    Int J Biochem Cell Biol; 2014 Sep; 54():266-71. PubMed ID: 24842108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells.
    Vaughan RA; Garcia-Smith R; Trujillo KA; Bisoffi M
    Prostate; 2013 Oct; 73(14):1538-46. PubMed ID: 23818177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes.
    Ehrke E; Arend C; Dringen R
    J Neurosci Res; 2015 Jul; 93(7):1138-46. PubMed ID: 25196479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
    Ihrlund LS; Hernlund E; Khan O; Shoshan MC
    Mol Oncol; 2008 Jun; 2(1):94-101. PubMed ID: 19383331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible regulatory role of glyoxalase I in cell viability of human prostate cancer.
    Davidson SD; Milanesa DM; Mallouh C; Choudhury MS; Tazaki H; Konno S
    Urol Res; 2002 May; 30(2):116-21. PubMed ID: 12086016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geissoschizine methyl ether protects oxidative stress-mediated cytotoxicity in neurons through the 'Neuronal Warburg Effect'.
    Sun J; Ren X; Qi W; Yuan D; Simpkins JW
    J Ethnopharmacol; 2016 Jul; 187():249-58. PubMed ID: 27114061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent.
    Dell'Antone P
    Med Chem; 2009 Nov; 5(6):491-6. PubMed ID: 19534685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of energy metabolism by 3-bromopyruvate in the hard tick Rhipicephalus microplus.
    Braz V; Gomes H; Galina A; Saramago L; Braz G; da Silva Vaz I; Logullo C; da Fonseca RN; Campos E; Moraes J
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Apr; 218():55-61. PubMed ID: 30580107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the glycolytic pathway by methylglyoxal in human platelets.
    Leoncini G; Maresca M; Buzzi E
    Cell Biochem Funct; 1989 Jan; 7(1):65-70. PubMed ID: 2752537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inorganic Selenium Induces Nonapoptotic Programmed Cell Death in PC-3 Prostate Cancer Cells Associated with Inhibition of Glycolysis.
    Cui J; Yan M; Liu X; Yin S; Lu S; Fan L; Hu H
    J Agric Food Chem; 2019 Sep; 67(38):10637-10645. PubMed ID: 31513389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria.
    Macchioni L; Davidescu M; Roberti R; Corazzi L
    J Bioenerg Biomembr; 2014 Oct; 46(5):389-94. PubMed ID: 25194986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate.
    Lis P; Dyląg M; Niedźwiecka K; Ko YH; Pedersen PL; Goffeau A; Ułaszewski S
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27983708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.
    Chiasserini D; Davidescu M; Orvietani PL; Susta F; Macchioni L; Petricciuolo M; Castigli E; Roberti R; Binaglia L; Corazzi L
    J Proteomics; 2017 Jan; 152():329-338. PubMed ID: 27890797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
    Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
    Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins.
    Bodur C; Karakas B; Timucin AC; Tezil T; Basaga H
    Mol Carcinog; 2016 Nov; 55(11):1584-1597. PubMed ID: 26373689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.